Pharmacotherapy for Leishmaniasis in the United States: Focus on Miltefosine

E-ISSN： 1875-9114|35|5|536-545

ISSN： 0277-0008

Source： PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol.35, Iss.5, 2015-05, pp. : 536-545

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oral treatment of visceral leishmaniasis with miltefosine

By Sundar S. Gupta L. B. Makharia M. K. Singh M. K. Voss A. Rosenkaimer F. Engel J. Murray H. W.

Annals of Tropical Medicine and Parasitology, Vol. 93, Iss. 6, 1999-09 ,pp. : 589-597

Routledge Ltd

Access to resources Recommend Favorite

Miltefosine in the treatment of a case of visceral leishmaniasis with renal dysfunction

By Kumar N. Pandey K. Das V. N. R. Sinha P. K. Topno R. K. Verma N. Lal C. S. Das P. Bhattacharya S. K.

Annals of Tropical Medicine and Parasitology, Vol. 101, Iss. 7, 2007-10 ,pp. : 649-651

Maney Publishing

Access to resources Recommend Favorite

Treatment of obesity: Pharmacotherapy trends in the United States from 1999 to 2010

OBESITY, Vol. 23, Iss. 8, 2015-08 ,pp. : 1721-1728

John Wiley & Sons Inc

Access to resources Recommend Favorite

Miltefosine to treat cutaneous leishmaniasis caused by Leishmania tropica

By Killingley B. Lamb L. E. M. Davidson R. N.

Annals of Tropical Medicine and Parasitology, Vol. 103, Iss. 2, 2009-03 ,pp. : 171-175

Maney Publishing

Access to resources Recommend Favorite

Miltefosine for visceral leishmaniasis relapse treatment and secondary prophylaxis in HIV-infected patients

By Marques Nuno Sa Rosa Coelho Filomena Oliveira Joaquim Saraiva Da Cunha J. Melico-Silvestre A.

Scandinavian Journal of Infectious Diseases, Vol. 40, Iss. 6-7, 2008-01 ,pp. : 523-526

Informa Healthcare

Access to resources Recommend Favorite